
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Propranolol in the Treatment of Essential Hypertension</dc:title>
  <dc:subject>Hypertension</dc:subject>
  <dc:subject>Antihypertensive Agents</dc:subject>
  <dc:subject>Adrenergic beta-Antagonists</dc:subject>
  <dc:subject>Propranolol</dc:subject>
  <dc:description>Propranolol, introduced in the mid-1960s, was the first beta-blocker to be widely used clinically. This study aimed to assess its effectiveness in comparison with standard hypertension treatments, such as hydralazine and reserpine.</dc:description>
  <dc:publisher>American Heart Association, 23 May 1977</dc:publisher>
  <dc:publisher>The American Heart Association, 23 May 1977</dc:publisher>
  <dc:contributor>Journal of the American Medical Association</dc:contributor>
  <dc:contributor>Veterans Administration Cooperative Study Group on Antihypertensive Agents</dc:contributor>
  <dc:type>Articles</dc:type>
  <dc:format>Archival Materials</dc:format>
  <dc:format>Text</dc:format>
  <dc:format>8 pages</dc:format>
  <dc:identifier>nlm:nlmuid-101584929X116-doc</dc:identifier>
  <dc:identifier>101584929X116</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101584929X116</dc:identifier>
  <dc:identifier>Profiles ID: XFBBHQ</dc:identifier>
  <dc:language>English</dc:language>
  <dc:relation>Profiles in Science</dc:relation>
</oai_dc:dc>